CONTROLLED FIELD TRIAL OF A TYPHOID VACCINE PREPARED WITH A NONMOTILE MUTANT OF SALMONELLA-TYPHI TY2

被引:0
|
作者
WAHDAN, MH
SIPPEL, JE
MIKHAIL, IA
RAHKA, AE
ANDERSON, ES
SPARKS, HA
CVJETANOVIC, B
机构
[1] ALEXANDRIA UNIV,HIGH INST PUBL HLTH,ALEXANDRIA,UNITED ARAB REP
[2] ABBASSIA FEVER HOSP,NAMRUS,CAIRO,UNITED ARAB REP
[3] CENT PUBL HLTH LAB,WHO ENTERIC REF CTR,LONDON,ENGLAND
[4] WHO,DIV COMMUN DIS,GENEVA,SWITZERLAND
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:69 / 73
页数:5
相关论文
共 50 条
  • [1] The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine Ty21a
    Robbe-Saule, V
    Norel, F
    [J]. FEMS MICROBIOLOGY LETTERS, 1999, 170 (01) : 141 - 143
  • [2] CONSTRUCTION OF A GENETICALLY DEFINED SALMONELLA-TYPHI TY2 AROA, AROC MUTANT FOR THE ENGINEERING OF A CANDIDATE ORAL TYPHOID TETANUS VACCINE
    CHATFIELD, SN
    FAIRWEATHER, N
    CHARLES, I
    PICKARD, D
    LEVINE, M
    HONE, D
    POSADA, M
    STRUGNELL, RA
    DOUGAN, G
    [J]. VACCINE, 1992, 10 (01) : 53 - 60
  • [3] GENOMIC CLEAVAGE MAP OF SALMONELLA-TYPHI TY2
    LIU, SL
    SANDERSON, KE
    [J]. JOURNAL OF BACTERIOLOGY, 1995, 177 (17) : 5099 - 5107
  • [4] A CONTROLLED FIELD TRIAL OF LIVE SALMONELLA-TYPHI STRAIN TY 21A ORAL VACCINE AGAINST TYPHOID - 3-YEAR RESULTS
    WAHDAN, MH
    SERIE, C
    CERISIER, Y
    SALLAM, S
    GERMANIER, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1982, 145 (03): : 292 - 295
  • [5] ATTENUATED TYPHOID VACCINE SALMONELLA-TYPHI TY21A - FINGERPRINTING AND DUALITY CONTROL
    MCKENNA, AJ
    BYGRAVES, JA
    MAIDEN, MCJ
    FEAVERS, IM
    [J]. MICROBIOLOGY-UK, 1995, 141 : 1993 - 2002
  • [6] EFFICACY OF LIVE ORAL TYPHOID VACCINE (SALMONELLA-TYPHI TY-21A) IN VOLUNTEER STUDIES AND FIELD TRIALS
    CRYZ, SJ
    FURER, E
    LEVINE, MM
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 118 (13) : 467 - 470
  • [7] A GALE-VIA (VI-ANTIGEN-NEGATIVE) MUTANT OF SALMONELLA-TYPHI TY2 RETAINS VIRULENCE IN HUMANS
    HONE, DM
    ATTRIDGE, SR
    FORREST, B
    MORONA, R
    DANIELS, D
    LABROOY, JT
    BARTHOLOMEUSZ, RCA
    SHEARMAN, DJC
    HACKETT, J
    [J]. INFECTION AND IMMUNITY, 1988, 56 (05) : 1326 - 1333
  • [8] EFFICACY OF ONE OR 2 DOSES OF TY21A SALMONELLA-TYPHI VACCINE IN ENTERIC-COATED CAPSULES IN A CONTROLLED FIELD TRIAL
    BLACK, RE
    LEVINE, MM
    FERRECCIO, C
    CLEMENTS, ML
    LANATA, C
    ROONEY, J
    GERMANIER, R
    [J]. VACCINE, 1990, 8 (01) : 81 - 84
  • [9] Infection of Caenorhabditis elegans by Salmonella typhi Ty2
    Santander, J
    Espinoza, JC
    Campano, MS
    Robeson, J
    [J]. ELECTRONIC JOURNAL OF BIOTECHNOLOGY, 2003, 6 (02): : 148 - 152
  • [10] ISOLATION OF STABLE AROA MUTANTS OF SALMONELLA-TYPHI TY2 - PROPERTIES AND PRELIMINARY CHARACTERIZATION IN MICE
    DOUGAN, G
    MASKELL, D
    PICKARD, D
    HORMAECHE, C
    [J]. MOLECULAR & GENERAL GENETICS, 1987, 207 (2-3): : 402 - 405